Bioceres Corp Solution Corp. (NYSE American: BIOX) disclosed that it has inked an agreement with Moolec Science Ltd. As per the agreement, Bioceres will buy 6% of holdings in Moolec Science Ltd. Moolec is a Molecular Framing firm that has gained recognition for engaging in a dual concept between plant and cell-based technologies for the production of animal-free food solutions.
Moolec is making products based on several crops to acquire highly functional complementary protein concentrates and isolates. The firm is intending to create animal-free solutions at a significantly decrease cost than that provided by current technologies, by leveraging the scalability of plant-based production systems to control the capabilities achieved through cellular agriculture.
Bioceres Corp Solution Corp. (NYSE American: BIOX) shares rocketed 22.47% as it gained +2.24 at the time of writing on Tuesday. Bioceres Corp Solution Corp.'s share price went from a low point around $4.35 to briefly over $10.15 in the past 52 weeks, though shares have since pulled back to $12.21. BIOX market cap has stayed high, striking $356.35M at the time of writing.
Moolec has also made history after making the first bovine protein originated from the altered safflower grain, a proprietary technology labeled under the SPC name. One of the reports disclosed that proteins market valuation attained USD 14.95 billion in 2019 and is anticipated to increase significantly over 2020-2025.